JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB131438

Anti-ERK1 (phospho Y204)抗体

Anti-ERK1 (phospho Y204) antibody

Be the first to review this product! Submit a review

|

(35 Publications)

Rabbit Polyclonal ERK1 phospho Y204 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 35 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK3 phospho Y204 aa 200-250 conjugated to Keyhole Limpet Haemocyanin.

查看别名

ERK1, PRKM3, MAPK3, Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellular signal-regulated kinase 1, Insulin-stimulated MAP2 kinase, MAP kinase isoform p44, Microtubule-associated protein 2 kinase, p44-ERK1, ERK-1, p44-MAPK

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-ERK1 (phospho Y204) antibody (AB131438)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-ERK1 (phospho Y204) antibody (AB131438)

Immunofluorescent analysis of methanol-fixed HeLa cells labelling ERK1 (phospho Y204) with ab131438 at 1/100 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ERK1 (phospho Y204) antibody (AB131438)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ERK1 (phospho Y204) antibody (AB131438)

Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue labelling ERK1 (phospho Y204) with ab131438 at 1/50 dilution. Right panel was preincubated with blocking peptide.

Western blot - Anti-ERK1 (phospho Y204) antibody (AB131438)
  • WB

Unknown

Western blot - Anti-ERK1 (phospho Y204) antibody (AB131438)

All lanes:

Western blot - Anti-ERK1 (phospho Y204) antibody (ab131438) at 1/500 dilution

Lane 1:

293 cell extract untreated

Lane 2:

293 cell extract treated with UV

Predicted band size: 43 kDa

false

Western blot - Anti-ERK1 (phospho Y204) antibody (AB131438)
  • WB

CiteAb

Western blot - Anti-ERK1 (phospho Y204) antibody (AB131438)

ERK1 (phospho Y204) western blot using anti-ERK1 (phospho Y204) antibody ab131438. Publication image and figure legend from Sui, H., Lou, A., et al., 2019, BMC Cancer, PubMed 30876463.

ab131438 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab131438 please see the product overview.

Lidocaine inhibited MEK/ERK and NF-κB pathways by up-regulating miR-145. a The phosphorylation of MEK/ERK and (b) p65 and IκBα were decreased by lidocaine. The phosphorylation of MEK/ERK, p65 and IκBα were analyzed by western blot. ** p < 0.01, *** p < 0.001

false

关键信息

宿主种属

Rabbit

克隆

Polyclonal

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

IHC-P, ICC/IF, WB

applications

免疫原

Synthetic Peptide within Human MAPK3 phospho Y204 aa 200-250 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P27361

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/200", "ICCIF-species-notes": "<p></p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
纯化说明
ab131438 was purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatography using non-phosphopeptide.
存储溶液
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
储存信息
Stable for 12 months at -20°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

ERK1 also known as MAPK3 is an extracellular signal-regulated kinase involved in transmitting signals from the cell surface to the nucleus. This protein has a molecular mass of about 44 kDa. ERK1 expresses in various tissue types with higher expression in the brain heart and skeletal muscle. Researchers often study ERK1 in the context of its role in cellular signaling due to its involvement in critical regulatory functions.
Biological function summary

ERK1 plays a significant role in cell cycle regulation differentiation and proliferation. It forms part of the MAPK signaling cascade becoming activated through a phosphorylation event. In its activated form ERK1 translocates to the nucleus where it phosphorylates target substrates. ERK1 often functions in conjunction with its homolog ERK2 to mediate these cellular processes marking it as an essential player in growth factor signaling.

Pathways

ERK1 functions primarily within the MAPK/ERK signaling pathway a major conduit for transmitting proliferative signals from growth factor receptors. ERK1 interacts with proteins like MEK1/2 which phosphorylate and activate ERK1 in response to extracellular stimuli. Another critical pathway involving ERK1 is the Ras-Raf-MEK-ERK cascade which regulates various cellular outcomes. This connection to the Ras family highlights its importance in signal transduction and reinforces its position in critical cellular processes.

Aberrant activation of ERK1 connects to diseases such as cancer and cardiovascular disorders. In cancer the dysregulation of the MAPK/ERK pathway often through mutations affecting Ras or Raf proteins leads to uncontrolled cell proliferation. ERK1's involvement in cardiovascular diseases links to its role in hypertrophic signaling in cardiac cells where altered ERK1 activity can contribute to pathological cardiac remodeling. Understanding these interactions can aid in developing therapeutic strategies targeting the MAPK/ERK signaling pathway.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed : 34497368). MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DEPTOR, FRS2 or GRB10) (PubMed : 35216969). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade.
See full target information MAPK3 phospho Y204

文献 (35)

Recent publications for all applications. Explore the full list and refine your search

Hereditas 162:119 PubMed40604895

2025

TIMP1 promotes microglia M2 polarization through MAPK pathway to ameliorate early brain injury after ischemia.

Applications

Unspecified application

Species

Unspecified reactive species

Kangkang Zhao,Zizhao Huang

Journal of biochemical and molecular toxicology 38:e23848 PubMed39264832

2024

GAD1 ameliorates glioma progression through regulating cuproptosis via RAS/MAPK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhiqiang Gao,Jing Yang

Cellular and molecular biology (Noisy-le-Grand, France) 70:85-91 PubMed38836676

2024

The combination of tetramethylpyrazine and vitamin A acid in the treatment of skin photoaging by activating the HIF-1α pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Weijun Chen,Jianyong Fan,Xuelian Zou,Yuansheng Wu

Journal of neuropathology and experimental neurology 83:161-167 PubMed38263262

2024

Angiogenic responses are enhanced by recombinant human erythropoietin in a model of periventricular white matter damage of neonatal rats through EPOR-ERK1 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Lihua Zhu,Qichao Yuan,Chunping Jing,Lingxian Sun,Li Jiang

Cellular and molecular life sciences : CMLS 80:156 PubMed37208565

2023

CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through mA-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Qi,Wenyi Shen,Xiyi Wei,Yifei Cheng,Fan Xu,Yuxiao Zheng,Lu Li,Chao Qin,Xiao Li

Cell biology international 46:1399-1408 PubMed35842767

2022

PIK3CB promotes oesophageal cancer proliferation through the PI3K/AKT/mTOR signalling axis.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Xu,Zhiqiang Wang,Zhi Zhang,Jian Xu,Yuequan Jiang

Evidence-based complementary and alternative medicine : eCAM 2022:8330926 PubMed35774749

2022

Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology.

Applications

Unspecified application

Species

Unspecified reactive species

Lanyu Li,Lukai Yang,Fang Liu,Jinfeng Qu

Bioengineered 13:5709-5723 PubMed35188450

2022

microRNA-211-5p predicts the progression of postmenopausal osteoporosis and attenuates osteogenesis by targeting dual specific phosphatase 6.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Wang,Xiaoyan Shi,Zhenye Guo,Feng Zhao,Weifu He,Mingming Kang,Zhi Lv

Oxidative medicine and cellular longevity 2021:9959746 PubMed34745428

2021

M1 Bone Marrow-Derived Macrophage-Derived Extracellular Vesicles Inhibit Angiogenesis and Myocardial Regeneration Following Myocardial Infarction via the MALAT1/MicroRNA-25-3p/CDC42 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Bairong Chen,Liyun Luo,Xiaoliang Wei,Dong Gong,Zhihui Li,Songbiao Li,Wenyi Tang,Lizi Jin

Pathology oncology research : POR 27:1609761 PubMed34257616

2021

MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Linlin Wang,Dan Liu,Jun Wei,Liwei Yuan,Shiyun Zhao,Yani Huang,Jingwen Ma,Zhijuan Yang
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com